DIAGNOSTIC & SCREENING Evidence-based Medicine. Pengalaman/Data Empiric Masalah experience-based...
-
Upload
monica-small -
Category
Documents
-
view
220 -
download
0
Transcript of DIAGNOSTIC & SCREENING Evidence-based Medicine. Pengalaman/Data Empiric Masalah experience-based...
DIAGNOSTIC & SCREENING
Evidence-based Medicine
Pengalaman/Data EmpiricPengalaman/Data Empiric
Masalah experience-based medicineMasalah experience-based medicine
Nilai-nilai kebenaranNilai-nilai kebenaran Nilai-nilai pembenaranNilai-nilai pembenaran
Appendisitis akutAppendisitis akutAppendisitis akutAppendisitis akut
Appendisitis akutAppendisitis akutAppendisitis akutAppendisitis akutMcBurney sign (+)McBurney sign (+)
McBurney sign (+)McBurney sign (+)
USGUSG 7676 9966CT ScanCT Scan 8383 9933USGUSG 7676 9966CT ScanCT Scan 8383 9933
USGUSG 8787 9988CT Scan CT Scan 9922 100 100USGUSG 8787 9988CT Scan CT Scan 9922 100 100
Use of USG vs. CT Scan in diagnosing acute appendicitisUse of USG vs. CT Scan in diagnosing acute appendicitis
SensitivitySensitivity Specificity Specificity SensitivitySensitivity Specificity Specificity
Negative appendectomy: 20-40%Negative appendectomy: 20-40%Negative appendectomy: 20-40%Negative appendectomy: 20-40%
Styrud et al, , Intl J for Quality in Health Care, 2000Styrud et al, , Intl J for Quality in Health Care, 2000
SensitivitySensitivity Specificity Specificity SensitivitySensitivity Specificity Specificity
PPatientatientOr Or
ProblemProblem
IInterventionntervention CComparisonomparison OOutcomesutcomes
AppendicitAppendicitisis
AppendicitAppendicitisis
CT scanCT scanCT scanCT scan USGUSGUSGUSGMore More
sensitive sensitive & specific& specific
More More sensitive sensitive & specific& specific
Clinical Question
PP II CC OO
Foreground QuestionForeground Question
Natural History of DiseaseNatural History of Disease
AAAA BBBB CCCC DDDD EEEE FFFF
A.A. Biologic onset of the conditionBiologic onset of the conditionB.B. Pathologic evidence of disease detectable by screeningPathologic evidence of disease detectable by screeningC.C. Signs and symptoms of diseaseSigns and symptoms of diseaseD.D. Health care soughtHealth care soughtE.E. Diagnosis of diseaseDiagnosis of diseaseF.F. Treatment of diseaseTreatment of disease
A.A. Biologic onset of the conditionBiologic onset of the conditionB.B. Pathologic evidence of disease detectable by screeningPathologic evidence of disease detectable by screeningC.C. Signs and symptoms of diseaseSigns and symptoms of diseaseD.D. Health care soughtHealth care soughtE.E. Diagnosis of diseaseDiagnosis of diseaseF.F. Treatment of diseaseTreatment of disease
PreclinicalPreclinicalPreclinicalPreclinical ClinicalClinicalClinicalClinical OutcomeOutcomeOutcomeOutcome
Issues in ScreeningIssues in Screening
Improve outcomes of illness Improve outcomes of illness • Improve morbidity: exampleImprove morbidity: example• Improve mortality: exampleImprove mortality: example
Improve outcomes of illness Improve outcomes of illness • Improve morbidity: exampleImprove morbidity: example• Improve mortality: exampleImprove mortality: example
DefinitionDefinitionDefinitionDefinition
Early detection of preclinical Early detection of preclinical disease in asymptomatic personsdisease in asymptomatic personsEarly detection of preclinical Early detection of preclinical disease in asymptomatic personsdisease in asymptomatic persons
Purpose of screeningPurpose of screeningPurpose of screeningPurpose of screening
DEFINITION: Screening
The assessment or evaluation of people, The assessment or evaluation of people, who have no symptoms of disease, in who have no symptoms of disease, in order to classify them as to likelihood of order to classify them as to likelihood of having a particular diseasehaving a particular disease
The assessment or evaluation of people, The assessment or evaluation of people, who have no symptoms of disease, in who have no symptoms of disease, in order to classify them as to likelihood of order to classify them as to likelihood of having a particular diseasehaving a particular disease
Difference Between Diagnostic and Difference Between Diagnostic and Screening TestScreening Test
Difference Between Diagnostic and Difference Between Diagnostic and Screening TestScreening Test
is used to confirm diagnosis is used to confirm diagnosis in a patient who is sickin a patient who is sickis used to confirm diagnosis is used to confirm diagnosis in a patient who is sickin a patient who is sick
is offered to subjects who are is offered to subjects who are free of symptoms or signs of free of symptoms or signs of diseasedisease
is offered to subjects who are is offered to subjects who are free of symptoms or signs of free of symptoms or signs of diseasedisease
Screening testScreening testScreening testScreening test
Diagnostic testingDiagnostic testingDiagnostic testingDiagnostic testing
ObjectivesObjectivesObjectivesObjectives
However, in clinical practice diagnostic results may be in error
However, in clinical practice diagnostic results may be in error
diagnosticdiagnosticdiagnosticdiagnostic screeningscreeningscreeningscreening
detect disease detect disease at all stageat all stage
detect disease detect disease at all stageat all stage
detect early detect early stage of diseasestage of disease
detect early detect early stage of diseasestage of disease
Examples Of Screening TestsExamples Of Screening TestsExamples Of Screening TestsExamples Of Screening Tests• Blood pressureBlood pressure• ScoliosisScoliosis• Vision/GlaucomaVision/Glaucoma• MammographyMammography• Pap smearsPap smears• CholesterolCholesterol• DiabetesDiabetes
• Blood pressureBlood pressure• ScoliosisScoliosis• Vision/GlaucomaVision/Glaucoma• MammographyMammography• Pap smearsPap smears• CholesterolCholesterol• DiabetesDiabetes
• DepressionDepression
• Nutrition Nutrition screeningscreening
• Drug/alcohol useDrug/alcohol use
• LeadLead
• AbuseAbuse
• Fall riskFall risk
• DepressionDepression
• Nutrition Nutrition screeningscreening
• Drug/alcohol useDrug/alcohol use
• LeadLead
• AbuseAbuse
• Fall riskFall risk
WHY WE NEED A WHY WE NEED A GOOD DIAGNOSTIC GOOD DIAGNOSTIC
TESTTEST
WHY WE NEED A WHY WE NEED A GOOD DIAGNOSTIC GOOD DIAGNOSTIC
TESTTEST
Widal agglutination testWidal agglutination test
ThypoiThypoidd
1.1. absence of infection by absence of infection by S typhiS typhi2.2. the carrier statethe carrier state3.3. an inadequate inoculum of bacterial an inadequate inoculum of bacterial
antigen in the host to induce antibody antigen in the host to induce antibody productionproduction
4.4. technical difficulty or errors in the technical difficulty or errors in the performance of the testperformance of the test
5.5. previous antibiotic treatmentprevious antibiotic treatment6.6. variability in the preparation of variability in the preparation of
commercial antigenscommercial antigens
1.1. absence of infection by absence of infection by S typhiS typhi2.2. the carrier statethe carrier state3.3. an inadequate inoculum of bacterial an inadequate inoculum of bacterial
antigen in the host to induce antibody antigen in the host to induce antibody productionproduction
4.4. technical difficulty or errors in the technical difficulty or errors in the performance of the testperformance of the test
5.5. previous antibiotic treatmentprevious antibiotic treatment6.6. variability in the preparation of variability in the preparation of
commercial antigenscommercial antigens
Causes of negative Widal agglutination tests
109 years after its invention (1896 – 2005)109 years after its invention (1896 – 2005)
Postgrad Med J 2000;76:80–84
1.1. the patient being tested has typhoid feverthe patient being tested has typhoid fever2.2. previous immunisation with previous immunisation with Salmonella Salmonella
antigen.antigen.3.3. cross-reaction with non-typhoidal cross-reaction with non-typhoidal SalmonellaSalmonella..4.4. variability and poorly standardised variability and poorly standardised
commercial antigen preparationcommercial antigen preparation5.5. infection with malaria or other infection with malaria or other
enterobacteriaceaeenterobacteriaceae6.6. other diseases such as dengueother diseases such as dengue
1.1. the patient being tested has typhoid feverthe patient being tested has typhoid fever2.2. previous immunisation with previous immunisation with Salmonella Salmonella
antigen.antigen.3.3. cross-reaction with non-typhoidal cross-reaction with non-typhoidal SalmonellaSalmonella..4.4. variability and poorly standardised variability and poorly standardised
commercial antigen preparationcommercial antigen preparation5.5. infection with malaria or other infection with malaria or other
enterobacteriaceaeenterobacteriaceae6.6. other diseases such as dengueother diseases such as dengue
Causes of positive Widal agglutination tests
• Multi-Test Dip-S-Ticks Multi-Test Dip-S-Ticks for Serotype Typhi for Serotype Typhi 89 89 50 50
• TyphiDot TyphiDot 79 79 89 89 • TUBEX TUBEX 78 78 94 94 • Widal testing in Widal testing in
the hospitalthe hospitalb b 64 64 7676• Widal testing at the Widal testing at the
Pasteur Institute Pasteur Institute 61 61 100 100
• Multi-Test Dip-S-Ticks Multi-Test Dip-S-Ticks for Serotype Typhi for Serotype Typhi 89 89 50 50
• TyphiDot TyphiDot 79 79 89 89 • TUBEX TUBEX 78 78 94 94 • Widal testing in Widal testing in
the hospitalthe hospitalb b 64 64 7676• Widal testing at the Widal testing at the
Pasteur Institute Pasteur Institute 61 61 100 100
Diagnostic toolDiagnostic tool Sensitivity Specificity Sensitivity Specificity (%)(%) (%) (%)
Diagnostic toolDiagnostic tool Sensitivity Specificity Sensitivity Specificity (%)(%) (%) (%)
Characteristics of ValidityCharacteristics of ValidityCharacteristics of ValidityCharacteristics of Validity
the ability of a test to determine those who do not have the disease
the ability of a test to correctly identify those who have the disease or condition
SensitivitSensitivityy
SpecificitSpecificityy
test result negatif
test result negatif
No treatment might be
given
No treatment might be
given
Wrong treatment
(medical error)
Wrong treatment
(medical error)
Test result
positive
Test result
positive
Diagnostic/screening
Diagnostic/screening
Misleading
Accurate
Best diagnostic tools
Highly sensitive/specific False positive/negative
PneumoniaPneumonia
NoNoPneumoniaPneumonia
PneumoniaPneumonia
NoNoPneumoniaPneumonia
PneumoniaPneumonia
No No PneumoniaPneumonia
DIAGNOSTIC TEST PROCEDUREDIAGNOSTIC TEST PROCEDURE
GOLD STANDARDGOLD STANDARD
RespiratoryRespiratoryraterate
Disease Disease (+)(+)
No No DiseaseDisease
Gold Standard for DxGold Standard for Dx
Disease(+Disease(+))
No DiseaseNo Disease
TTEESSTT
True True positivepositive
True True negativenegative
False False negativenegative
False False positivepositive
Sensitivity& Specificity Sensitivity& Specificity Sensitivity& Specificity Sensitivity& Specificity
How to calculate these How to calculate these using a 2 X 2 tableusing a 2 X 2 table
How to calculate these How to calculate these using a 2 X 2 tableusing a 2 X 2 table
aa b b
cc d d
Disease Disease (+)(+)
No No DiseaseDisease
Gold Standard for DxGold Standard for Dx
Disease(+Disease(+))
No DiseaseNo Disease
TTEESSTT
a + ca + c b + db + d
Sensitivity = a / (a+c) x 100%Sensitivity = a / (a+c) x 100%Sensitivity = a / (a+c) x 100%Sensitivity = a / (a+c) x 100%
Sensitivity is the ability of the test to detect the presence Sensitivity is the ability of the test to detect the presence of diseaseof disease
is the proportion of patients with disease who test positive
Sensitivity = Sensitivity = 90%90%
of those who have anemia, 90% will test of those who have anemia, 90% will test positivepositiveof those who have anemia, 90% will test of those who have anemia, 90% will test positivepositiveIt also means that in those that have It also means that in those that have anemia, 10% will test negative (i.e. there is anemia, 10% will test negative (i.e. there is a 10% false negative rate in those with a 10% false negative rate in those with anemia)anemia)
It also means that in those that have It also means that in those that have anemia, 10% will test negative (i.e. there is anemia, 10% will test negative (i.e. there is a 10% false negative rate in those with a 10% false negative rate in those with anemia)anemia)
Diagnostic test for anemia using ferritinDiagnostic test for anemia using ferritin
anemiaanemia Dx testDx test
Positive = 90%Positive = 90%
Negative = 10%Negative = 10%Negative = 10%Negative = 10%
aa b b
cc d d
Disease (+)Disease (+) No No DiseaseDisease
Gold Standard for DxGold Standard for Dx
Disease(+)Disease(+)
No DiseaseNo Disease
TTEESSTT
a + ca + c b + db + d
Specificity = d / (b+d) x 100%Specificity = d / (b+d) x 100%Specificity = d / (b+d) x 100%Specificity = d / (b+d) x 100%
Specificity is the ability of the test to detect the absence Specificity is the ability of the test to detect the absence of diseaseof disease
is the proportion of patients without disease who test negative
Spesificity = 85%Spesificity = 85%
of those who do not have anemia, 85% will test of those who do not have anemia, 85% will test negativenegative
It also means that in those that do not have It also means that in those that do not have anemia, 15% will test positive (i.e. there is a anemia, 15% will test positive (i.e. there is a 15% false positive rate in those without 15% false positive rate in those without anemia)anemia)
Diagnostic test for anemia using ferritinDiagnostic test for anemia using ferritin
Non anemiaNon anemia Dx testDx test
Positive = 15 Positive = 15 %%Positive = 15 Positive = 15 %%
Negative = 85%Negative = 85%
If a defined population of patients is being If a defined population of patients is being evaluated, the pretest probability is equal evaluated, the pretest probability is equal to the prevalence of disease in the to the prevalence of disease in the population. population.
If a defined population of patients is being If a defined population of patients is being evaluated, the pretest probability is equal evaluated, the pretest probability is equal to the prevalence of disease in the to the prevalence of disease in the population. population.
Pretest ProbabilityPretest Probability
• is the estimated likelihood of disease is the estimated likelihood of disease before the test is donebefore the test is done
• = prior probability= prior probability
• is the estimated likelihood of disease is the estimated likelihood of disease before the test is donebefore the test is done
• = prior probability= prior probability
It is the proportion of total patients who It is the proportion of total patients who have the disease. have the disease. It is the proportion of total patients who It is the proportion of total patients who have the disease. have the disease.
Note that ………………………..Note that ………………………..Note that ………………………..Note that ………………………..
Sensitivity is calculated based only Sensitivity is calculated based only on those who have disease, andon those who have disease, andSensitivity is calculated based only Sensitivity is calculated based only on those who have disease, andon those who have disease, and
Therefore, neither sensitivity nor Therefore, neither sensitivity nor specificity are affected by the specificity are affected by the prevalence of the target conditionprevalence of the target condition
specificity is calculated only on those specificity is calculated only on those who do not have diseasewho do not have diseasespecificity is calculated only on those specificity is calculated only on those who do not have diseasewho do not have disease
The trade off between sensitivity and specificity
The trade off between sensitivity and specificity
In most cases as sensitivity increases, specificity decreases, and vice versa (i.e they are inversely related to each other
In most cases as sensitivity increases, specificity decreases, and vice versa (i.e they are inversely related to each other
The Sensitivity/specificity trade offThe Sensitivity/specificity trade off
An example of when you might want An example of when you might want a high sensitivity is a screen for a high sensitivity is a screen for neonatal hypothyroidism (you neonatal hypothyroidism (you wouldnwouldn’’t want many false negatives t want many false negatives which might lead to irreversible which might lead to irreversible cognitive damagecognitive damage
The Sensitivity/specificity trade offThe Sensitivity/specificity trade off
An example of when you might want An example of when you might want a a high specificityhigh specificity is a screen for HIV is a screen for HIV (you wouldn(you wouldn’’t want many false t want many false positives due to the emotional positives due to the emotional trauma)trauma)
(Knapp and Miller, 1992)
““ . . . individuals with the condition who . . . individuals with the condition who are correctly identified as diseased by are correctly identified as diseased by the new testthe new test””
““ . . . individuals with the condition who . . . individuals with the condition who are correctly identified as diseased by are correctly identified as diseased by the new testthe new test””
True positive:True positive:True positive:True positive:
False positive:False positive:False positive:False positive:
. . . individuals without the condition who . . . individuals without the condition who are falsely identified as diseased by the are falsely identified as diseased by the new testnew test””. This is also referred to as a . This is also referred to as a mis-diagnosis.mis-diagnosis.
. . . individuals without the condition who . . . individuals without the condition who are falsely identified as diseased by the are falsely identified as diseased by the new testnew test””. This is also referred to as a . This is also referred to as a mis-diagnosis.mis-diagnosis.
True negativeTrue negativeTrue negativeTrue negative
““ . . . individuals without the condition . . . individuals without the condition who are correctly identified as who are correctly identified as diseased-free by the new testdiseased-free by the new test””
““ . . . individuals without the condition . . . individuals without the condition who are correctly identified as who are correctly identified as diseased-free by the new testdiseased-free by the new test””
False negative:False negative:False negative:False negative:
““ . . . individuals with the condition who . . . individuals with the condition who are falsely identified as disease-free by are falsely identified as disease-free by the new testthe new test””. This is also referred to as . This is also referred to as a missed diagnosis.a missed diagnosis.
““ . . . individuals with the condition who . . . individuals with the condition who are falsely identified as disease-free by are falsely identified as disease-free by the new testthe new test””. This is also referred to as . This is also referred to as a missed diagnosis.a missed diagnosis.
• ““ . . . probability that an individual with a . . . probability that an individual with a positive test result has the disease. positive test result has the disease.
• PVP is also known as the PVP is also known as the posterior posterior probability, positive predictive valueprobability, positive predictive value or or posttest probabilityposttest probability or disease or disease””
• ““ . . . probability that an individual with a . . . probability that an individual with a positive test result has the disease. positive test result has the disease.
• PVP is also known as the PVP is also known as the posterior posterior probability, positive predictive valueprobability, positive predictive value or or posttest probabilityposttest probability or disease or disease””
• ““ . . . probability that an individual with a . . . probability that an individual with a negative test result does not have the negative test result does not have the disease. disease.
• PVN is also known as PVN is also known as negative predictive negative predictive valuevalue””
• ““ . . . probability that an individual with a . . . probability that an individual with a negative test result does not have the negative test result does not have the disease. disease.
• PVN is also known as PVN is also known as negative predictive negative predictive valuevalue””
Predictive Value PositivePredictive Value Positive (PVP) (PVP)Predictive Value PositivePredictive Value Positive (PVP) (PVP)
Predictive Value NegativePredictive Value NegativePredictive Value NegativePredictive Value Negative
• Predictive value of a positive test is Predictive value of a positive test is the proportion of patients with the proportion of patients with positivepositive tests who have disease. tests who have disease.
• This is the same thing as posttest This is the same thing as posttest probability of disease given a positive probability of disease given a positive test. It measures how well the test test. It measures how well the test rules in disease. rules in disease.
• Predictive value of a positive test is Predictive value of a positive test is the proportion of patients with the proportion of patients with positivepositive tests who have disease. tests who have disease.
• This is the same thing as posttest This is the same thing as posttest probability of disease given a positive probability of disease given a positive test. It measures how well the test test. It measures how well the test rules in disease. rules in disease.
aa b b
cc d d
Disease (+)Disease (+) No No DiseaseDisease
Gold Standard for DxGold Standard for Dx
Disease(+)Disease(+)
No DiseaseNo Disease
TTEESSTT
Positive Predictive Value (PV+) = (a/a+b) X 100 (%)Positive Predictive Value (PV+) = (a/a+b) X 100 (%)
+ PV = a/ (a+b)
• = Posttest probability= Posttest probability• = = the proportion of patients with the proportion of patients with positivepositive
tests who have diseasetests who have disease
• = Posttest probability= Posttest probability• = = the proportion of patients with the proportion of patients with positivepositive
tests who have diseasetests who have disease
aa b b
cc d d
Disease (+)Disease (+) No No DiseaseDisease
Gold Standard for DxGold Standard for Dx
Disease(+)Disease(+)
No DiseaseNo Disease
TTEESSTT
Negative Predictive Value (PV-) = (d/c+d) X 100 (%)Negative Predictive Value (PV-) = (d/c+d) X 100 (%)
Proportion of true negatives among all Proportion of true negatives among all those with negatives resultsthose with negatives results
- PV = d/ (c+d)
Note that ………………………..Note that ………………………..
Positive and negative predictive Positive and negative predictive values are calculated using both values are calculated using both those with disease, and those those with disease, and those without diseasewithout disease
Therefore, both positive and negative Therefore, both positive and negative predictive values are affected by predictive values are affected by prevalence of the target conditionprevalence of the target condition
Pneumonia
No Pneumoni
a
Pneumonia
NoPneumonia
RESPIRATORY
CHEST X-RAY
a b
c d - PV = d/ (c+d)
+ PV = a/ (a+b)
Sensitivity a / (a+c)
Specificity d / (b+d)
Pneumonia
No Pneumoni
a
Pneumonia
NoPneumonia
RESPIRASI
FOTO RONTGEN
a b
c d
Accuracy = (a+d) / N
Prevalence = (a+c) / N
a/a + cLR + = ----------
b/b + d
c/a + cLR - = ----------
d/b + d
Pneumonia
No Pneumoni
a
Pneumonia
NoPneumonia
RESPIRASI
FOTO RONTGEN
a b
c d
Probability of having the test result positive among those who have disease
Probability of having the test result positive among those who have disease
Likelihood ratio positive:Likelihood ratio positive:
Probability of having the test result negative among those who don’t have disease
Probability of having the test result negative among those who don’t have disease
Likelihood ratio negative:Likelihood ratio negative:
Diagnostic test for anemia using ferritin
Test-Treatment Threshold
Post-test probabilityPost-test probability
LIKELIHOOD RATIO
• Probability of having a test result (positive or negative) in a person with disease compared to the test result (positive or negative) of person with disease free
LR (+) = 12,3 LR (-) = 0,39
What does this mean?
1. Is this evidence about the accuracy of a
diagnostic test valid?
Primary questions for Diagnostic Test
2. Does this (valid) evidence demonstrate an important ability of this test to accurately distinguish patients who do and don’t have a specific disorder?
3. Can I apply this valid, important diagnostic test to a specific patient?
1. Was there an independent, blind comparison with a reference (“gold”) standard of diagnosis?
2. Was the diagnostic test evaluated in an appropriate spectrum of patients (like those in whom we would use it in practice)?
3. Was the reference standard applied regardless of the diagnostic test result?
4. Was the test (or cluster of tests) validated in a second, independent group of patients?
Is this evidence about a diagnostic test valid?
1. Was there an independent, blind comparison with a reference (“gold”) standard of diagnosis?
diagnostic test in questiondiagnostic test in question
• history or • physical
examination, • a blood test
• history or • physical
examination, • a blood test
“gold” standard“gold” standard
• autopsy or • biopsy • autopsy or • biopsy
BLINDING
1. Was there an independent, blind comparison with a reference (“gold”) standard of diagnosis?
2. Was the diagnostic test evaluated in an appropriate spectrum of patients (like those in whom we would use it in practice)?
3. Was the reference standard applied regardless of the diagnostic test result?
4. Was the test (or cluster of tests) validated in a second, independent group of patients?
Is this evidence about a diagnostic test valid?
highhigh
mediummedium
low clinical suspicionlow clinical suspicion
35 35 positipositiveve
35 35 positipositiveve
Carcino Embryonic Carcino Embryonic Antigen (CEA)Antigen (CEA) mildmild colon/ colon/
RectRectal canceral cancermildmild colon/ colon/
RectRectal canceral cancer
otherother gastro gastro--intestinal intestinal cancercancer
otherother gastro gastro--intestinal intestinal cancercancer
36 36 advanced advanced colon/colon/ rectumrectum
cancercancer
36 36 advanced advanced colon/colon/ rectumrectum
cancercancer
PoorPooraccuracyaccuracy
PoorPooraccuracyaccuracy
1. Was there an independent, blind comparison with a reference (“gold”) standard of diagnosis?
2. Was the diagnostic test evaluated in an appropriate spectrum of patients (like those in whom we would use it in practice)?
3. Was the reference standard applied regardless of the diagnostic test result?
4. Was the test (or cluster of tests) validated in a second, independent group of patients?
Is this evidence about a diagnostic test valid?
Do more good
Invasive
Was the reference standard applied regardless of the diagnostic test result?
Was the reference standard applied regardless of the diagnostic test result?
Standard
Standard
Do more harm
Non invasiveNEGATIF
1. Was there an independent, blind comparison with a reference (“gold”) standard of diagnosis?
2. Was the diagnostic test evaluated in an appropriate spectrum of patients (like those in whom we would use it in practice)?
3. Was the reference standard applied regardless of the diagnostic test result?
4. Was the test (or cluster of tests) validated in a second, independent group of patients?
Is this evidence about a diagnostic test valid?
Disease (+)
Disease (-)
Disease (+)
Disease (-)
Was the test (or cluster of tests) validated in a second, independent group of patients?
Study Patiens
IndependentGroup
1. Is the dx test available, affordable, accurate, and precise in our setting?
2. Can we generate a clinically sensible estimate of our patient’s pre-test probability?
· From personal experience, prevalence statistics, practice databases, or primary studies· Are the study patients similar to our own?· Is it unlikely that the disease possibilities or probabilities have changed since this evidence was gathered?
3. Will the resulting post-test probabilities affect our management and help our patient?
· Could it move us across a test-treatment threshold?· Would our patient be a willing partner in carrying it out?· Would the consequences of the test help our patient reach his or her goals in all this?
Table 2 applying a valid diagnostic test to anindividual patient
Table 2 applying a valid diagnostic test to anindividual patient
1. Is the dx test available, affordable, accurate, and precise in our setting?
availableavailable
affordableaffordable
accurateaccurate
PrecisePreciseEXPERT????
2. Can we generate a clinically sensible estimate of our patient’s pre-test probability?• From personal experience, prevalence
statistics, practice databases, or primary studies
Diagnostic tests that produce big changes from pretest to post-test probabilities are important and
likely to be useful to us in our practice
Diagnostic tests that produce big changes from pretest to post-test probabilities are important and
likely to be useful to us in our practice
“pre-test” probability (what we estimated before the test)
“pre-test” probability (what we estimated before the test)
“post-test” probability(what we estimates after the test)
“post-test” probability(what we estimates after the test)
2. Can we generate a clinically sensible estimate of our patient’s pre-test probability?• Are the study patients similar to our own?• Is it unlikely that the disease possibilities or
probabilities have changed since this evidence was gathered?
Widal
AppendicitisHipertension
Typhoid???Typhoid???
Mc Burney vs. USGMc Burney vs. USG
Criteria of hipertensionCriteria of hipertension
Sensitivity =Specificity = LR + =LR – =PPV =NPV =Prevalence =Pre-test odds =Post-test odds =Post-test prob =
731 270 100178 1500 1578809 1770 2579
Dx testresult(ferritin)
(+) (<65ml/L)(-) (>65ml/L)
Target disorder(iron deficiency anemia) Totals
Present Absent
a/(a + c) = 731/809 = 90%d/(b + d) = 1500/1770 = 85%sens/(1 – spec) = 90%/15% = 6(1 – sens)/spec = 10%/85% = 0.12a/(a + b) = 731/1001 = 73%d/(c + d) = 1500/1578 = 95%(a + c)/(a + b + c + d) = 809/2579 = 32%.prevalence/(1 – prevalence) = 31%/69% = 0.4pre-test odds × likelihood ratio.post-test odds/(post-test odds + 1).